12.07.2015 Views

Guidelines for ATC classification and DDD assignment ... - WHOCC

Guidelines for ATC classification and DDD assignment ... - WHOCC

Guidelines for ATC classification and DDD assignment ... - WHOCC

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Further reviews of <strong>DDD</strong>sAfter the first three years period, the <strong>DDD</strong> normally remains unchanged <strong>for</strong> at leastfive years unless the WHO Working Group decides to make a total revision of all<strong>DDD</strong>s assigned in an <strong>ATC</strong> group. Proposed <strong>DDD</strong> changes from users of thesystem, based on new in<strong>for</strong>mation will always be considered, but only after thethree years revision has been per<strong>for</strong>med.E. Description of other drug utilization metricsCostDrug use can be expressed in terms of costs (e.g. national currency). Cost figuresare suitable <strong>for</strong> an overall cost analysis of drug expenditure. National <strong>and</strong>international comparisons based on cost parameters are often misleading <strong>and</strong> oflimited value in the evaluation of drug use. Price differences between alternativepreparations <strong>and</strong> different national cost levels make the evaluation difficult. Longtermstudies are also difficult due to fluctuations in currency <strong>and</strong> changes in prices.When cost data are used, an increase in the use of cheaper drugs may have littleinfluence on the total level, while a shift to more expensive drugs is more readilynoticed.VolumeCommon physical units (e.g. grams, kilos, litres), numbers of packages or tablets<strong>and</strong> numbers of prescriptions are also used <strong>for</strong> quantifying drug consumption.These units can be applied only when the use of one drug or well defined productsis evaluated. Problems arise, however, when the consumption of whole druggroups is considered.If consumption is given in terms of grams of active ingredients, drugs with lowpotency will have a larger fraction of the total than drugs with high potency.Combined products may also contain different amounts of active ingredients fromplain products, which will not be reflected in the figures.Counting numbers of tablets also has disadvantages, because strengths of tabletsvary, with the result that low strength preparations contribute relatively more thanhigh strength preparations. Also, short-acting preparations will often contributemore than long-acting preparations.Numbers of prescriptions do not give a good expression of total use, unless totalamounts of drugs per prescription are also considered. Counting of prescriptions,however, is of great value in measuring the frequency of prescriptions <strong>and</strong> inevaluating the clinical use of drugs (e.g. diagnosis <strong>and</strong> dosages used).30

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!